InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Nolan Sean P., Director. Insider active across 3 companies, notably Taysha Gene Therapies, Inc.. Aggregated, 7 filings have been logged. Total volume traded: €43k. The latest transaction was filed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
€157,8572,047 shares@ €77.11640.0004% mcap100.0% of flow
Common Stock
SEC:0001569926-26-000012·
€157,8572,047 shares@ €77.11640.0004% mcap32.8% of flow
Common Stock
SEC:0001569926-26-000012:0·
€165,7553,056 shares@ €54.23920.0004% mcap34.4% of flow
Common Stock
SEC:0000740260-22-000111:0·
03,158 shares0
Common Stock
SEC:0000740260-21-000134·
03,158 shares0
Common Stock
SEC:0000740260-21-000134:0·
€21,3901,170 shares@ €18.2816100.0% of flow
Common Stock
SEC:0001209191-21-035165·
Ideal exit: 14 Feb 2022 (T+270)
€21,3901,170 shares@ €18.28160.0012% mcap50.0% of flow
Common Stock
SEC:0001209191-21-035165:0·
Ideal exit: 14 Feb 2022 (T+270)
7 of 7 declarations
About Nolan Sean P.
Sean P. Nolan serves as a Board Member at Taysha Gene Therapies, Inc. and Ventas, Inc. He contributes to the governance and strategy of these companies. Taysha Gene Therapies specializes in gene therapies, while Ventas is a provider of healthcare real estate services. Sean P. Nolan brings his expertise to the board, helping to guide strategic decisions and oversee operations.
